IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Arizona

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Arizona $ 7,503,090.80
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
AmpliMed Corporation Development of small-molecule anti-cancer drugs $ 244,479.24  
Apthera, Inc. NeuVax-adjuvant treatment for node positive breast cancer with low to intermediate HER2 $ 244,479.25  
Ardent Sound Inc. Development of Ultrasound Therapy Device for Sebaceous and Sweat Gland Treatment $ 244,479.25  
Ascalon International Inc IV Fenretinide $ 106,406.50 $ 138,072.74
bioVidria, Inc. Integrated platform for glycoform biomarker discovery $ 47,799.50 $ 114,302.50
BLUE HORSE LABS, INC. TGEN COLLABORATION: GENETIC RISK FACTORS FOR ALZHEIMER'S DISEASE (PHASE II) $ 179,589.50 $ 8,301.50
Blue Horse Labs, Inc. Oxidative stress markers in multiple matrices as biomarkers for disease $ 7,160.00 $ 88,697.00
Calimmune, Inc. Hematopoietic Stem Cell Therapy for HIV/AIDS Usifng RNAi to Reduce Expression of CCR5 $ 244,479.25  
Cancer Prevention Pharmaceuticals Inc Eflornithine $ 189,893.77 $ 54,585.48
Capstone Therapeutics Corp AZX100 for Idiopathic Pulmonary Fibrosis (IPF) $ 78,150.00 $ 166,329.24
Cold Plasma Medical Technologies Harmonic Cold Plasma medical Technology for the Repair of Living Cells, Tissue and organs.   $ 244,479.25
Eye Care and Cure Corporation Extra-Ocular Motility Monitor (EOMM)   $ 63,720.71
Eye Care and Cure Corporation I-CORE   $ 53,221.15
Gary A Flynn PhD/Spacefill Enterprises LLC Multi-targeted Kinase Inhibitors as Imaging and Therapeutic Agents   $ 27,000.00
High Throughout Genomics, Inc. qNPA miRNA Development Project $ 41,483.00 $ 5,419.00
High Throughput Genomics, Inc Mid Density Platform Development Project $ 73,830.00 $ 79,962.00
High Throughput Genomics, Inc qBead Development Project $ 67,940.00 $ 38,392.00
High Throughput Genomics, Inc Fusin Gene-SNV Mutation Tests Development Project $ 26,268.50 $ 28,273.50
High Throughput Genomics, Inc Pathogen Assay Development Project $ 11,131.00 $ 23,394.00
High Throughput Genomics, Inc DLBCL & Cell of Orgin Development Project $ 16,408.50 $ 8,707.00
High Throughput Genomics, Inc qSelect Assay Archive Development Project $ 16,026.50 $ 41,378.50
High Throughput Genomics, Inc qNPA Platform Technology Development Project $ 71,709.50 $ 117,348.00
High Throughput Genomics, Inc Melanoma Screening Development Project   $ 20,359.50
High Throughput Genomics, Inc Radiation Exposure Monitoring Assay Development Project $ 13,797.00 $ 2,081.00
Hope Medical Enterprises, Inc Treatment of Acute Myocardial Infarction   $ 17,542.28
Hope Medical Enterprises, Inc. Treatment of Sickle Cell Disease $ 3,250.00 $ 36,907.86
HumaGene Inc Recombinant fibrogen & thrombin $ 17,985.00 $ 14,500.00
InNexus Biotechnology, Inc. DXL 625 $ 116,760.00  
INSYS Therapeutics, Inc Fentanyl Sublingual Spray $ 244,479.24  
INSYS Therapeutics, Inc Dronabinol Oral Solution   $ 244,479.25
Kinetic Muscles Inc Neuro Telerehabilitation System $ 221,667.65 $ 22,811.59
MedApps, Inc Utilizing the MedApps System for Remotely Monitoring Clinical Drug Therapies $ 244,479.24  
MSDx Multiple Sclerosis Diagnostics, LLC Biomarkers for Monitoring Multiple Sclerosis Patients - A Window into the Brain $ 82,908.19 $ 47,063.66
MSDx, Inc Biomarkers for Monitoring Multiple Sclerosis Patients - A window into the Brain   $ 74,700.00
PathoGene, LLC Development of molecular assays for the identification and resistance profiling of MRSA.   $ 37,850.50
Protein Genomics Engineered Small-Diameter Artery Grafts Using Synthesized Human Elastin $ 120,342.50 $ 124,136.75
Provista Life Sciences, LLC Fibrinogen and fibrin degradation product lung cancer assay   $ 137,175.27
Provista Life Sciences, LLC Multivariate Breast Cancer Detection and Screening Assay $ 221,153.46  
Provista Life Sciences, LLC Epigenetic Test for Alzheimer's Disease   $ 244,479.25
Provista Life Sciences, LLC Lymphocyte Proliferation Test for Early Alzheimer's Detection $ 180,664.68  
Prugen IP Holdings Inc Drug Bioavailability Enhancement Delivery System $ 244,479.25  
Rowpar Pharmaceuticals, Inc Stabilized Chlorine Dioxide for Treatment & Prevention of Oral Candidiasis $ 1,402.50 $ 3,673.00
Rowpar Pharmaceuticals, Inc 0.5% Stabilized Chlorine Dioxide for the Treatment and Prevention for Gingivitis $ 2,881.00 $ 20,782.50
SALUTARIS MEDICAL DEVICES, INC. SMD-A $ 244,479.24  
Sensys Medical Inc Non-invasive boold glucose monitor for the diagnosis & treatment of diabetes $ 244,479.24  
Southwest Scientific Editing & Consulting, LLC Dietary supplements enhanced for biofavanoids and antioxidants to treat human disease $ 2,850.00 $ 26,200.00
Susavion Biosciences, Inc Discovery of Immunotherapeutic Drugs Against Viral Infections $ 85,997.50 $ 117,631.00
Synbuild LLC Kit for noninvasive early detection of pancreatic cancer   $ 11,157.12
SYNCARDIA SYSTEMS, INC. COMPANION 2 DRIVER   $ 54,080.75
Thayer Medical Corporation Inline acuator for pMDI medication delivery in ventilator circuits with 15 mm connection. $ 66,050.50 $ 112,333.50
Transmed Oncology Inc Pre-Clinical and Clinical Development of DNMT1 inhibiting Compounds $ 70,784.50  
Valley Fever Solutions, Inc. Late Stage Valley Fever - Phase II   $ 244,479.25
Vomaris Innovations, Inc The Use of Bioelectric Wound Care Devices for Improving Healthcare   $ 244,479.25

 

Page Last Reviewed or Updated: 04-Jun-2014